Rising incidence of degenerative disorders and chronic diseases is projected to be the primary driver behind cell therapy market growth. Growing use of cell therapies to treat various diseases and high investments in cell research are also expected to create new opportunities for market players in the future. Advancements in stem cell research and growing demand for regenerative medicine are also expected to foster new business scope for cell therapy providers going forward. High demand for personalized medicine is also estimated to uplift the demand for cell therapies across the forecast period and beyond. On the contrary, high costs of development, risk of rejection, and complex regulatory approval procedures are estimated to be key restraints for cell therapy market over the coming years.
Global Cell Therapy Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 8.38 billion in 2024 to USD 39.81 billion by 2032, growing at a CAGR of 21.5% during the forecast period (2025-2032).
The Cell Therapy Market is witnessing notable growth due to increasing demand across various industries and advancements in technology. Factors such as rising consumer awareness, evolving regulations, and the push for sustainable and innovative solutions are driving market expansion. Additionally, the adoption of Cell Therapy Market is fueled by its versatile applications and growing focus on efficiency, quality, and performance.
Get a Free Sample PDF of the Report – http://www.skyquestt.com/sample-request/cell-therapy-market
Cell Therapy Market Recent Developments:
This year in January 2024, Kite Pharma received approval for a new CAR-T manufacturing process that will help speed up the turnaround times for Yescarta-related therapies. This approval will help shorten manufacturing time by 2 days, making it 5 days from the previous 7 days.
Back again in January 2024, Fate Therapeutics announced the start of its new Phase I clinical trial in collaboration with Ono Pharmaceutical of solid tumour therapy. Chimeric antigen receptor (CAR) T-cell therapy is being used to treat solid tumours and this trial assesses its safety and tolerability among patients.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Cell Therapy Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Cell Therapy Market is segmented by Technology, Type, Cell Type, Cell Source, Application, End-User and region.
Based on Technology, the market is segmented into Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology and Three-Dimensional Technology.
Based on Type, the market is segmented into Autologous and Allogeneic.
Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell.
Based on Cell Source, the market is segmented into iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues and Neural Stem Cell.
Based on Application, the market is segmented into Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds and Injuries, Ocular and Others.
Based on End-User, the market is segmented into Hospitals and Clinics, Regenerative Medicine Centres, Diagnostic and Research Centres and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Cell Therapy Market – Regional Analysis:
North America is projected to account for a dominant share of the global cell therapy market in the future. High investments in medical R&D, the presence of key biotechnology companies, and supportive government funding are key factors that are estimated to help the high market share of this region. Canada and the United States are slated to be the top markets for cell therapy companies in this region. High demand for cell therapies to treat chronic diseases will also favor market growth in this region.
Asia Pacific is expected to emerge as the fastest-expanding market for cell therapies in the world going forward. Growing awareness regarding benefits of cell therapies, high investments in healthcare infrastructure development, and rising acceptance of cell therapies are top factors that will create new opportunities for cell therapy companies in the future. Japan, China, and India are slated to be the key markets in this region.
Top Market Players in Cell Therapy Market are:
Novartis AG (Switzerland)
Gilead Sciences, Inc. (USA)
Bristol Myers Squibb (USA)
Johnson & Johnson (USA)
Takeda Pharmaceutical Company Limited (Japan)
Bluebird Bio, Inc. (USA)
Mesoblast Limited (Australia)
CRISPR Therapeutics (Switzerland)
Adaptimmune Therapeutics plc (UK)
Fate Therapeutics, Inc. (USA)
Orchard Therapeutics plc (UK)
Gamida Cell Ltd. (Israel)
Allogene Therapeutics, Inc. (USA)
Capricor Therapeutics, Inc. (USA)
Vericel Corporation (USA)
Mustang Bio, Inc. (USA)
Atara Biotherapeutics, Inc. (USA)
Take Action Now: Secure Your Cell Therapy Market Today – http://www.skyquestt.com/buy-now/cell-therapy-market
Cell Therapy Key Market Trends:
CAR-T Cell Therapy:
The prevalence of cancer has increased exponentially on a global level and so has the need for novel treatments as well. CAR-T (Chimeric Antigen Receptor T-cell) therapy is emerging as a popular immunotherapy for the treatment of various cancers, companies can capitalize on this trend to maximize their business scope in the long run.
Forward-Looking Insights
The Cell Therapy Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
